124
Views
4
CrossRef citations to date
0
Altmetric
Original Research

The Safety of Early Thromboembolic Prophylaxis in Closed Traumatic Intracranial Hemorrhage

Pages 81-85 | Published online: 14 Apr 2020

References

  • Knudson MM, Lewis FR, Clinton A, Atkinson K, Megerman J. Prevention of venous thromboembolism in trauma patients. J Trauma. 1994;37:480–487. doi:10.1097/00005373-199409000-00025
  • Browd SR, Ragel BT, Davis GE, Scott AM, Skalabrin EJ, Couldwell WT. Prophylaxis for deep venous thrombosis in neurosurgery: a review of the literature. Neurosurg Focus. 2004;17(4):E1. doi:10.3171/foc.2004.17.4.1
  • Selby R, Geerts W, Ofosu FA, et al. Hypercoagulability after trauma: hemostatic changes and relationship to venous thromboembolism. Thromb Res. 2009;124(3):281–287. doi:10.1016/j.thromres.2008.10.002
  • Reiff DA, Haricharan RN, Bullington NM, et al. Traumatic brain injury is associated with the development of deep vein thrombosis independent of pharmacological prophylaxis. J Trauma. 2009;66:1436–1440. doi:10.1097/TA.0b013e31817fdf1c
  • Praeger AJ, Westbrook AJ, Nichol AD, et al. Deep vein thrombosis and pulmonary embolus in patients with traumatic brain injury: a prospective observational study. Crit Care Resusc. 2012;14(1):10–13.
  • Ekeh AP, Dominguez KM, Markert RJ, McCarthy MC. Incidence and risk factors for deep venous thrombosis after moderate and severe brain injury. J Trauma. 2010;68(4):912–915. doi:10.1097/TA.0b013e3181b21cad
  • Hoffman H, Jalal MS, Chin LS. The risk factors, outcomes, and costs associated with venous thromboembolism after traumatic brain injury: a nationwide analysis. Brain Inj. 2019;16:1–8.
  • Froelich M, Ni Q, Wess C, Ougorets I, Härtl R. Continuous hypertonic saline therapy and the occurrence of complications in neurocritically ill patients. Crit Care Med. 2009;37(4):1433–1441. doi:10.1097/CCM.0b013e31819c1933
  • Byrne JP, Mason SA, Gomez D, et al. Timing of pharmacologic venous thromboembolism prophylaxis in severe traumatic brain injury: a propensity-matched cohort study. J Am Coll Surg. 2016;223(4):621–631.e5. doi:10.1016/j.jamcollsurg.2016.06.382
  • Cote LP, Greenberg S, Caprini JA, et al.; RIETE Investigators. Outcomes in neurosurgical patients who develop venous thromboembolism: a review of the RIETE registry. Clin Appl Thromb Hemost. 2014;20(8):772–778. doi:10.1177/1076029614532008
  • Geerts WH, Jay RM, Code KI, et al. A comparison of low-dose heparin with low-molecular-weight heparin as prophylaxis against venous thromboembolism after major trauma. N Engl J Med. 1996;335(10):701–707. doi:10.1056/NEJM199609053351003
  • Knudson MM, Morabito D, Paiement GD, Shackleford S. Use of low molecular weight heparin in preventing thromboembolism in trauma patients. J Trauma Acute Care Surg. 1996;41(3):446–459. doi:10.1097/00005373-199609000-00010
  • Menaker J, Stein DM, Scalea TM. Incidence of early pulmonary embolism after injury. J Trauma Acute Care Surg. 2007;63(3):620–624. doi:10.1097/TA.0b013e31812f60aa
  • Gould MK, Garcia DA, Wren SM, et al. Prevention of VTE in nonorthopedic surgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: american college of chest physicians evidence-based clinical practice guidelines. Chest. 2012;141(Suppl 2):e227S–e277S. doi:10.1378/chest.11-2297
  • Dudley RR, Aziz I, Bonnici A, et al. Early venous thromboembolic event prophylaxis in traumatic brain injury with low-molecular-weight heparin: risks and benefits. J Neurotrauma. 2010;27(12):2165–2172. doi:10.1089/neu.2010.1366
  • Kimmell KT, Jahromi BS. Clinical factors associated with venous thromboembolism risk in patients undergoing craniotomy. J Neurosurg. 2015;122(5):1004–1011. doi:10.3171/2014.10.JNS14632
  • Algattas H, Kimmell KT, Vates GE, Jahromi BS. Analysis of venous thromboembolism risk in patients undergoing craniotomy. World Neurosurg. 2015;84(5):1372–1379. doi:10.1016/j.wneu.2015.06.033
  • Ianosi B, Gaasch M, Rass V, et al. Early thrombosis prophylaxis with enoxaparin is not associated with hematoma expansion in patients with spontaneous intracerebral hemorrhage. Eur J Neurol. 2019;26(2):333–341. doi:10.1111/ene.13830
  • Wu TC, Kasam M, Harun N, et al. Pharmacological deep vein thrombosis prophylaxis does not lead to hematoma expansion in intracerebral hemorrhage with intraventricular extension. Stroke. 2011;42(3):705–709. doi:10.1161/STROKEAHA.110.600593
  • Khaldi A, Helo N, Schneck MJ, Origitano TC. Venous thromboembolism: deep venous thrombosis and pulmonary embolism in a neurosurgical population. J Neurosurg. 2011;114(1):40–46. doi:10.3171/2010.8.JNS10332
  • Chazova IE, Mychka VB, Mamyrbaeva KM, Gornostaev VV, Dvoskina IM, Sergienko VB. [Cerebrovascular complications in metabolic syndrome: possible approaches to decrease risk]. Ter Arkh. 2004;76(6):74–80. Russian.
  • Li S, Eisenstadt R, Kumasaka K, et al. Does enoxaparin interfere with HMGB1 signaling after TBI? A potential mechanism for reduced cerebral edema and neurologic recovery. J Trauma Acute Care Surg. 2016;80(3):381. doi:10.1097/TA.0000000000000935
  • Li S, Marks JA, Eisenstadt R, et al. Enoxaparin ameliorates post-traumatic brain injury edema and neurologic recovery, reducing cerebral leukocyte endothelial interactions and vessel permeability in vivo. J Trauma Acute Care Surg. 2015;79:78–84. doi:10.1097/TA.0000000000000697
  • Baharvahdat H, Ganjeifar B, Etemadrezaie H, Farajirad M, Zabihyan S, Mowla A. Enoxaparin in the treatment of severe traumatic brain injury: a randomized clinical trial. Surg Neurol Int. 2019;10:10. doi:10.4103/sni.sni_112_18